These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 406170)

  • 1. Multivesicular structures and effects of some aggregation inhibitors in guinea-pig platelets.
    Candia Carnevali M; Salimbeni S; Spelta A
    Haematologica; 1977 Apr; 62(2):127-35. PubMed ID: 406170
    [No Abstract]   [Full Text] [Related]  

  • 2. Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigs.
    Bergamaschi M; Ceserani R; Pierucci L; Pogliani E; Spelta A
    Pharmacol Res Commun; 1979 Mar; 11(3):279-94. PubMed ID: 461494
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by a new synthetic compound: 2-[p-(1-oxo-2-isoindolinyl)phenyl] butyric acid (K 3920).
    Di Perri T; Vittoria A; Laghi Pasini F
    Arzneimittelforschung; 1979; 29(1):104-6. PubMed ID: 582103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of 14C-labelled 2-[p-(1-oxo-2-isoindolinyl)phenyl]butyric acid, (indobufen or K 3920) in blood, platelets and platelet components.
    Vinazzer H; Zolle I; Fuccella LM; Valzelli G
    Thromb Res; 1980 Feb 1-15; 17(3-4):303-16. PubMed ID: 7368166
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
    Akman N
    Haematologica; 1980 Aug; 65(4):546-51. PubMed ID: 6774930
    [No Abstract]   [Full Text] [Related]  

  • 7. New pyridazino[4,5-b]indole derivatives with inodilator and antiaggregatory activities.
    Monge A; Aldana I; Losa MJ; Font M; Cenarruzabeitia E; Castiella E; Frechilla D; Santiago E; Martínez de Irujo JJ; Alberdi E
    Arzneimittelforschung; 1993 Nov; 43(11):1175-80. PubMed ID: 8292060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of BM 15075 on the blood coagulation system and on interaction with oral anticoagulants].
    Hoffrichter A; Zimmermann R; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1584-6. PubMed ID: 347788
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood platelet function after chronic treatment of rats and guinea pigs with nicotine.
    Becker BF; Terres W; Kratzer M; Gerlach E
    Klin Wochenschr; 1988; 66 Suppl 11():28-36. PubMed ID: 3184777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indobufen treatment in type IIA hypercholesterolemic subjects: effects on platelet function and malondialdehyde production.
    Tremoli E; Maderna P; Sirtori M; Colli S; Corvi G; Sirtori CR
    Pharmacol Res Commun; 1981 Oct; 13(9):847-59. PubMed ID: 7335762
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
    Gürsoy AZ; Yardimci TU; Emekli NB; Ugur MS; Ulutin ON
    Haematologica; 1981 Dec; 66(6):756-67. PubMed ID: 6802717
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of thromboxane antagonist EP 045 on platelet aggregation.
    Jones RL; Wilson NH; Armstrong RA; Peesapati V; Smith GM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():345-50. PubMed ID: 6303074
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
    Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
    Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osmotic shock of platelets. II. Influence of different chemicals. Osmotic shock on filtered platelets (author's transl)].
    García-Conde J; Benet I; Merino J
    Sangre (Barc); 1977; 22(4):426-36. PubMed ID: 897953
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathoracic platelet accumulation in the guinea-pig induced by intravenous administration of arachidonic acid--effect of cyclooxygenase and thromboxane synthetase inhibitors.
    Barrett PA; Butler KD; Shand RA; Wallis RB
    Thromb Haemost; 1986 Dec; 56(3):311-7. PubMed ID: 3105107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.